Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Negrin

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Journal of Hematotherapy|January 1, 1992
Use of the polymerase chain reaction for the detection of tumor cell involvement of bone marrow and peripheral blood: implications for purgingR S Negrin
Current Opinion in Hematology|November 14, 1998
Minimal residual diseaseR S Negrin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocationsR S Negrin, J Pesando
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 1997
Cellular immunotherapy following autologous hematopoietic progenitor cell transplantationP H Lu, R S Negrin
Blood|July 15, 1991
The use of the polymerase chain reaction for the detection of minimal residual malignant diseaseR S Negrin, K G Blume
The Journal of Biological Chemistry|April 10, 1978
Ferrichrome transport in inner membrane vesicles of Escherichia coli K12R S Negrin, J B Neilands
Hematological Oncology|May 11, 1999
Engraftment of chronic myeloid leukemia in SCID miceC F Hoyle, R S Negrin
Drug Safety|June 1, 1993
Use and toxicity of the colony-stimulating factorsJ R Schriber, R S Negrin
Journal of Hematotherapy|March 21, 1998
CD34 enumerationA L Pecora, R S Negrin
Advances in Pharmacology (San Diego, Calif.)|January 1, 1992
Therapy of hematopoietic disorders with recombinant colony-stimulating factorsR S Negrin, P L Greenberg
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Journal of Hematotherapy|January 1, 1992
Use of the polymerase chain reaction for the detection of tumor cell involvement of bone marrow and peripheral blood: implications for purgingR S Negrin
Current Opinion in Hematology|November 14, 1998
Minimal residual diseaseR S Negrin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocationsR S Negrin, J Pesando
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 1997
Cellular immunotherapy following autologous hematopoietic progenitor cell transplantationP H Lu, R S Negrin
Blood|July 15, 1991
The use of the polymerase chain reaction for the detection of minimal residual malignant diseaseR S Negrin, K G Blume
The Journal of Biological Chemistry|April 10, 1978
Ferrichrome transport in inner membrane vesicles of Escherichia coli K12R S Negrin, J B Neilands
Hematological Oncology|May 11, 1999
Engraftment of chronic myeloid leukemia in SCID miceC F Hoyle, R S Negrin
Drug Safety|June 1, 1993
Use and toxicity of the colony-stimulating factorsJ R Schriber, R S Negrin
Journal of Hematotherapy|March 21, 1998
CD34 enumerationA L Pecora, R S Negrin
Advances in Pharmacology (San Diego, Calif.)|January 1, 1992
Therapy of hematopoietic disorders with recombinant colony-stimulating factorsR S Negrin, P L Greenberg
Pageof 10